News – Page 3 – Alligator Bioscience

2017-03-23

Regulatory

Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013

Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that the first phase I study with ADC-1013, a human, ...

2017-03-222022-09-20

Regulatory

Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announces that that the Swedish version of Annual Report for 20 ...

2017-03-22

The shareholders of Alligator Bioscience AB, Reg. No 556597-8201, are hereby invited to attend the annual shareholders’ meeting to be held o ...

2017-02-17

Regulatory

Summary During the quarter were the company’s shares listed for trading on Nasdaq Stockholm Mid Cap. In connection with this were new shares ...

2017-02-15

Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that it will host a teleconference in connection to p ...

2017-01-31

Regulatory

During December, the number of shares and votes in Alligator Bioscience AB (publ) has increased due to that 700,000 warrants in the warrant ...